1. Baseline Characteristics of the Subjects
Ronald C. Petersen et al N Engl J Med 2005;352:

2. Kaplan - Meier Estimates of the Rate of Progression from Mild Cognitive Impairment to Alzheimer ’s Disease (AD)
Ronald C. Petersen et al N Engl J Med 2005;352:

3. Changes from Baseline in Cognitive and Functional Measures Part 1
Ronald C. Petersen et al N Engl J Med 2005;352:

4. Changes from Baseline in Cognitive and Functional Measures Part 2
Ronald C. Petersen et al N Engl J Med 2005;352:

5. Hazard Ratios for the Risk of Progression to Alzheimer ’s Disease in the Donepezil and Vitamin E Groups as Compared with the Placebo Group
Ronald C. Petersen et al N Engl J Med 2005;352:

6. Adverse Events
Ronald C. Petersen et al N Engl J Med 2005;352: